Arsenite selectively inhibits mouse bone marrow lymphoid progenitor cell development in vivo and in vitro and suppresses humoral immunity in vivo

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Ezeh, Peace C ^a   Lauer, Fredine T ^a   MacKenzie, Debra ^a   McClain, Shea ^a   Liu, Ke Jian ^a   Hudson, Laurie G ^a   Gandolfi, A Jay ^b   Burchiel, Scott W ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; CD11B ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; DRINKING WATER; ENDOGLIN; METHANEARSONIC ACID; ARSENOUS ACID DERIVATIVE; TERATOGENIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HELPER CELL; HEMATOPOIETIC STEM CELL; HUMORAL IMMUNITY; IMMUNOTOXICITY; LYMPHOID PROGENITOR CELL; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; SPLEEN CELL; T LYMPHOCYTE; ANIMAL; BONE MARROW CELL; CELL DIFFERENTIATION; CFU COUNTING; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; SPLEEN;

ANIMALS; ARSENITES; BONE MARROW CELLS; CELL DIFFERENTIATION; COLONY-FORMING UNITS ASSAY; IMMUNITY, HUMORAL; LYMPHOID PROGENITOR CELLS; MICE; SPLEEN; TERATOGENS;

EID: 84899531284     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093920     Document Type: Article

References (41)

1. Argos M, Kalra T, Rathouz PJ, Chen Y, Pierce B, et al. (2010) Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet 376: 252-258.
2. Nielson MG, Lombard PJ, Schalk LF (2010) Assessment of arsenic concentrations in domestic well water, by town, in Maine 2005-09: US Geological Survey Scientific Investigations Report 2010-5199, p.69.
3. Thomas DJ, Styblo M, Lin S (2001) The cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharmacol 176: 127-144. (Pubitemid 33015863)
4. Liu Z, Styblo M, Rosen BP (2006) Methylarsonous acid transport by aquaglyceroporins. Environ Health Perspect 114: 527-531.
5. Drobna Z, Naranmandura H, Kubachka KM, Edwards BC, Herbin-Davis K, et al. (2009) Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. Chem Res Toxicol. 22: 1713-1720.
6. Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, et al. (2000) Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol 74: 289-299. (Pubitemid 30660931)
7. Kozul CD, Ely KH, Enelow RI, Hamilton JW (2009) Low-dose arsenic compromises the immune system response to influenza A infection in vivo. Environ Health Perspect 117:1441-1447.
8. Cheng HY, Li P, David M, Smithgall TE, Feng L, et al. (2004) Arsenic inhibition of the JAK-STAT pathway. Oncogene 23: 3603-3612. (Pubitemid 38658427)
9. Argos M, Kibiriya MG, Parvez F, Jasmine F, Rakibuz-Zaman M et al. (2006) Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in Bangladeshi population. Cancer Epidemiol Biomarkers Prev 15: 1367-1375. (Pubitemid 44125296)
10. Flora SJ (2011) Arsenic-induced oxidative stress and its reversibility. Free Radic Biol Med 51: 257-281.
11. Hughes MF, Beck BD, Chen Y, Lewis AS, Thomas DJ (2011) Arsenic exposure and toxicology: a historical perspective. Toxicol Sci 123: 305-332.
12. King BS, Cooper KL, Liu KJ, Hudson LG (2012) Poly(ADP-ribose) contributes to an association between poly(ADP-ribose) polymerase-1 and xeroderma pigmentosum complementation group A in nucleotide excision repair. J Biol Chem. 287: 39824-39833.
13. Qin XJ, Liu W, Li YN, Sun X, Hai CX, et al. (2012) Poly (ADP-ribose) polymerase-1 inhibition by arsenite promotes the survival of cells with unrepaired DNA lesions induced by UV exposure. Toxicol Sci 127: 120-129.
14. Cooper KL, King BS, Sandoval MM, Liu KJ, Hudson LG (2013) Reduction of arsenite-enhanced ultraviolet radiation-induced DNA damage by supplemental zinc. Toxicol Appl Pharmacol 269: 81-88.
15. Sun X, Zhou X, Du L, Liu W, Liu Y, et al. (2013) Arsenite binding-induced zinc loss from PARP-1 is equivalent to zinc deficiency in reducing PARP-1 activity, leading to inhibition of DNA repair. Toxicol Appl Pharmacol [Epub ahead of print]
16. Carsetti R (2000) The development of B cells in the bone marrow is controlled by the balance between cell-autonomous mechanisms and signals from the microenvironment. J Exp Med 191: 5-8.
17. Biswas R, Ghosh P, Banerjee N, Das JK, Sau T, et al. (2008) Analysis of T-cell proliferation and cytokine secretion in the individuals exposed to arsenic via drinking water. Hum Exp Toxicol 27: 381-386
18. Banerjee N, Banerjee S, Sen R, Bandyopadhyay A, Sarma N, et al. (2009) Chronic arsenic exposure impairs macrophage functions in the exposed individuals. J Clin Immunol 29: 582-594.
19. Rocha-Amador DO, Calderon J, Costilla-Salazar R, Perez-Maldonado IN (2011) Apoptosis of peripheral blood mononuclear cells in children exposed to arsenic and fluoride. Environ Toxicol Pharmacol 32: 399-405.
20. Li Q, Lauer FT, Liu KJ, Hudson LG, Burchiel SW (2010) Low-dose synergistic immunosuppression of T-dependent antibody responses by polycyclic aromatic hydrocarbons and arsenic in C57BL/6J murine spleen cells. Toxicol Appl Pharmacol 245:344-351.
21. Kozul CD, Nomikos AP, Hampton TH, Warnke LA, Gosse JA, et al, (2008) Laboratory diet profoundly alters gene expression and confounds genomic analysis in mouse liver and lung. Chem Biol Interact. 173: 129-140.
22. Lauer FT, Walker MK and Burchiel SW. (2013) Oral exposure to dibenzo[def,p]-chrysene (DBC) suppresses antibody formation in murine spleen cells. J Toxicol Environ Health, 76: 16-24.
23. Randall TD, Lund FE, Howard MC, Weissman IL. (1996) Expression of murine CD38 defines a population of long-term reconstituting hematopoietic stem cells. Blood. 87: 4057-4067. (Pubitemid 26152248)
24. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 8: 315-317. (Pubitemid 44269669)
25. Andrew AS, Burgess JL, Meza MM, Demidenko E, Waugh MG, et al. (2006) Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. Environ Health Prespect 114: 1193-1198. (Pubitemid 44184676)
26. Soto-Pena GA, Luna AL, Acosta-Saavedra L, Conde-Moo P, Lopez-Carrillo L, et al.(2006) Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. FASEB J 20: 779-781. (Pubitemid 46671213)
27. Morzadec C, Bouezzedine F, Macoch M, Fardel O, Vernhet L (2012) Inorganic arsenic impairs proliferation and cytokine expression in human primary T lymphocytes. Toxicology 300: 46-56.
28. Morzadec C, Macoch M, Robineau M, Sparfel L, Fardel O, et al. (2012) Inorganic arsenic represses interleukin-17A expression in human activated Th17 lymphocytes. Toxicol Appl Pharmacol 262: 217-222.
29. Macoch M, Morzadec C, Fardel O, Vernhet L. (2013) Inorganic arsenic impairs differentiation and functions of human dendritic cells. Toxicol Appl Pharmacol 266: 204-213.
30. Vernhet L, Morzadec C, van Grevenynghe J, Bareau B, Corolleur M, et al. (2008) Inorganic arsenic induces necrosis of human CD34-positive haematopoietic stem cells. Environ Toxicol 23: 263-268 (Pubitemid 351458217)
31. Lengfelder E, Hofmann WK, Nowak D (2012) Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia. Leukemia 26: 433-442.
32. Irons, RD (ed) Toxicology of the Blood and Bone Marrow, Raven Press, New York, 1985.
33. Ahmed S, Ahsan KB, Kippler M, Mily A, Wagatsuma Y, et al. (2012) In utero arsenic exposure is associated with impaired thymic function in newborns possibly via oxidative stress and apoptosis. Toxicol Sci 129: 305-314.
34. Burchiel SW, Mitchell LA, Lauer FT, Sun X, McDonald JD, et al. (2009) Immunotoxicity and biodistribution analysis of arsenic trioxide in C57Bl/6 mice following a 2-week inhalation exposure. Toxicol Appl Pharmacol 241: 253-259.
35. Aposhian HV, Gurzau ES, Le XC, Gurzau A, Healy SM, et al. (2000) Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem Res Toxicol 13: 693-697. (Pubitemid 30663445)
36. Gamble MV, Liu X, Slavkovich V, Pilsner JR, Ilievski V, et al. (2007). Folic acid supplementation lowers blood arsenic. Am J Clin Nutr. 86, 1202-1209 (Pubitemid 47538328)
37. Meza M, Gandolfi AJ, Klimecki WT. (2007). Developmental and genetic modulation of arsenic biotransformation: a gene by environment interaction? Toxicol Appl Pharmacol 222:381-387. (Pubitemid 47198274)
38. Fujihara J, Soejima M, Yasuda T, Koda Y, Agusa T, et al. (2010) Global analysis of genetic variation in human arsenic (+3 oxidation state) methyltransferase (AS3MT). Toxicol Appl Pharmacol 243: 292-299.
39. Engström KS, Hossain MB, Lauss M, Ahmed S, Raqib R, et al. (2013) Efficient arsenic metabolism - the AS3MT haplotype is associated with DNA methylation and expression of multiple genes around AS3MT. PLoS One 8: e53732.
40. Healy SM, Casarez EA, Ayala-Fierro F, Aposian H (1998) Enzymatic methylation of arsenic compounds: V. arsenite methyltransferase activity in tissues of mice. Toxicol Appl Pharmacol 148: 65-70. (Pubitemid 28072777)
41. Engstrom K, Vahter M, Mlakar SJ, Concha G, Nermell B, et al. (2011) Polymorphisms in arsenic (+III oxidation state) methyltransferase (AS3MT) Predict GeneExpression of AS3MT as well as arsenic metabolism. Environ Health Perspect. 119: 182-188.